_latest-punjabi-movie-2018-bhai-taru-singh-touching-music-releasing-april-27-2018.jpg "Latest Punjabi Movie 2018 Bhai Taru Singh - Touching Music - Releasing April 27, 2018 from 2018 imo Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 12 sec
✓ Published: 31-Mar-2018
✓ Published: 31-Mar-2018
Description:
Watch the official trailer to learn more, https://youtu.be/NLzuow0-iMonnKanwar Grewal, Jaspinder Narula, and Sidhu Tajpuri have lent their heavenly voices to the project. nnWe request everyone to visit the theatres to watch the animated film on Bhai Taru Singh Ji.
Watch the official trailer to learn more, https://youtu.be/NLzuow0-iMonnKanwar Grewal, Jaspinder Narula, and Sidhu Tajpuri have lent their heavenly voices to the project. nnWe request everyone to visit the theatres to watch the animated film on Bhai Taru Singh Ji.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_2018-imo-problem-6-solution.webp "RedPig")
_icd-10-cm-2019-updates.webp "IMO Webinar | September 14, 2018nnPresenters:nJune Bronnert, MSHI, RHIA, CCS, CCS-P, Director, Terminology Coding, IMOnTheresa Rihanek, MHA, RHIA, CCS, International Mapping LeadnJulie Glasgow, MD, Senior Clinical Terminologist")
_58th-international-mathematical-olympiad-imo-2017.webp "58th International Mathematical Olympiad IMO 2017")
_2018-imo-problem-5-solution.webp "RedPig")
_imo-2018-problem-1-solution.webp "Super Exatas")
_2018-imo-problem-4-124124-this-one-is-hard.webp "n choose k")
_illuminate-301-ipilimumab-versus-imo-2125-combined-with-ipilimumab-in-anti-pd-1-refractory-melanoma.webp "Prof Paolo Ascierto speaks to ecancer at ESMO 2018 in Munich about the ILLUMINATE 301 trial, a phase 3 randomised comparison of ipilimumab alone versus IMO-2125 combined with ipilimumab in subjects with anti PD 1 refractory melanoma.nnProf Ascierto recaps the findings of phase 1 and the likely timeline of phase 3.nnHe also discusses the relevant findings of CheckMate 067, also presented at ESMO 2018, which uses ipilimuma combined with nivolumab.")
ILLUMINATE 301: ipilimumab versus IMO-2125 combined with ipilimumab in anti PD 1 refractory melanoma
⏲ 2 min 38 sec ✓ 22-Oct-2018
_top-20-country-by-international-mathematical-olympiad-gold-medal-1959-2019.webp "WawamuStats")
⏲ 2 minutes 21 seconds 👁 708.4K
_2018-imo-problem-6-solution.jpg)
_icd-10-cm-2019-updates.jpg)
_58th-international-mathematical-olympiad-imo-2017.jpg)
_2018-imo-problem-5-solution.jpg)
_imo-2018-problem-1-solution.jpg)
_2018-imo-problem-4-124124-this-one-is-hard.jpg)
_illuminate-301-ipilimumab-versus-imo-2125-combined-with-ipilimumab-in-anti-pd-1-refractory-melanoma.jpg)
_top-20-country-by-international-mathematical-olympiad-gold-medal-1959-2019.jpg)
![[+]](/images/menu.gif){kind=small}